Produktname:(1S,3S)-3-Amino-1-(Boc-amino)cyclopentane
IUPAC Name:tert-butyl N-[(1S,3S)-3-aminocyclopentyl]carbamate
- CAS：645400-44-8
- Molekulare Formel：C10H20N2O2
- Reinheit：95%
- Katalognummer：CM117739
- Molekulargewicht：200.28
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:645400-44-8
- Molekulare Formel:C10H20N2O2
- Schmelzpunkt:-
- SMILES-Code:O=C(N[C@@H]1C[C@@H](N)CC1)OC(C)(C)C
- Dichte:
- Katalognummer:CM117739
- Molekulargewicht:200.28
- Siedepunkt:
- Mdl-Nr.:MFCD11877864
- Lagerung:Keep in dark place, store at 2-8°C.
Category Infos
- Cyclopentanes
- Cyclopentane is a cycloalkane, an organic compound with a molecular formula of C5H10, a colorless and transparent liquid, insoluble in water, soluble in most organic solvents such as ethanol, ether, benzene, carbon tetrachloride, acetone, etc. It is mainly used as a solvent and chromatographic reference materials.
- Cyclopentanes,where to buy Cyclopentanes
- Cyclopentanes
- Cyclopentane (also called C pentane) is a highly flammable alicyclic hydrocarbon with chemical formula C5H10 and CAS number 287-92-3, consisting of a ring of five carbon atoms each bonded with two hydrogen atoms above and below the plane. It occurs as a colorless liquid with a petrol-like odor.
Column Infos
- Cyclanes
- Cyclanes are secondary metabolites that can be found in plants, and are also biochemicals that can be used in medicine. Cyclanes are found in pine trees, and are used in the making of plastics. Cyclenes are found in cinnamon, and have antifungal properties.
- KB-0742
- Kronos Bio announces the first patient dosed in an expansion cohort with KB-0742 at a dose of 80mg given on a four-days-on, three-days-off schedule. This expansion cohort is enrolling platinum-resistant patients with high-grade serous ovarian cancer (HGSOC). Many cancers exhibit transcriptional deregulation, often characterized by gene amplifications of MYC family oncogene. Targeting the transcription elongation cofactor, cyclin-dependent kinase 9 (CDK9) has emerged as a therapeutic strategy to disrupt MYC oncogenic activity.
KB-0742 is an oral highly selective CDK9 inhibitor designed for the treatment of patients with MYC-amplified and other transcriptionally addicted relapsed or refractory solid tumors, including ovarian, lung, and triple-negative breast cancers.
Suche 
+86 21 5895 0110 
